Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyratech Regulatory News (TYR)

  • There is currently no data for TYR

Trading Update

22 Sep 2008 07:00

RNS Number : 9263D
TyraTech, Inc.
22 September 2008
Β 

ο»Ώ

For immediate release

22Β September 2008

TYRATECH, INC.

("TyraTech" or "the Company")

Trading UpdateΒ 

TyraTech, Inc. (AIM: TYR), a leading independent novel pesticide company for human, animal and environmental health, today announces an update on trading.

TyraTech's commercial programmes are progressing well. However, due to the lengthy nature of commercial discussions with partners and customers, as well as TyraTech's disciplined approach to partner selection and deal negotiation, the Board anticipates that revenues and profits for the full year 2008 are unlikely to meet with current market expectations. The Company does, however, expect to report on positive progress from sales and partnership discussions before year end.

Revenue generating products and near term cash flowsΒ 

TyraTech's lead insecticide product, Naturalsβ„’ Crawling Insect Killer, has enjoyed growth in distribution outlets in theΒ USΒ via own label sales and a local distribution partner, SYSCO.

TyraTech's WasteSolver business is progressing well as evidenced by the growing customer pipeline and receipt of four signed orders plus a further four signed letters of intent. While sales of this product have been initially slower than expected due to the extended sales lead time necessary for farmers to evaluate the new waste management solution, customer feedback and the current order book confirm management's confidence in this product line.

Partnerships and milestones

TyraTech has diversified revenue streams which combine strong relationships with blue-chip partners and direct sales. The Company is actively involved in several partnership discussions with new partners covering consumer products, agriculture andΒ animal health, and has a signedΒ letter of intent in place with one significantΒ USΒ business for one of these key markets. The Board of TyraTech expects positive commercial progress and newsflow in the near to medium term on these discussions. However, despite real progress, signatures and timing of new partnerships and product launches have proved difficult to predict. In addition, whilst TyraTech reports that existing partner development programmes are progressing well, related milestones are now not expected until H1 2009.

Financials

The Company will announce its interim results onΒ 26 September 2008Β where revenue for the first half of the year is anticipated to be approximately $2.4 million with an operating loss of $9.8 million. The cash balance at the end of June 2008 was $14.9 million which the Board expects to be sufficient for the Company's current operations.Β 

Based on recent progress in the pipeline, work with current and future partners and new scheduled product releases, TyraTech expects to report strong growth in 2009. The Company's revenues are also expected to continue growing throughout H2 2008.

Commenting on the announcement, Douglas Armstrong Ph.D., Chief Executive Officer of TyraTech, said:Β "TyraTech has a diversified business model with revenue potentially arising from a number of different sources. We continue to receive strong feedback from our customers, and have made progress across all markets. We are therefore confident we can deliver successfully on our current and new potential partnerships.

"While the business operations have progressed well, we have been disappointed at the speed of entry into certain markets. As a management team we remain positive that we can execute our business plan and strategy and that there is potential for high gross margins on products and up front and milestone payments from partnering and licensing deals. We trust to be able to evidence this progress through announcements for the rest of 2008 which will have a positive impact on 2009 revenues."

For further information please contact:

TyraTech Inc.

Keith Bigsby, Chief Financial Officer +1 (321) 409 7714

www.tyratech.com

Nomura Code Securities

Charles Walker +44 (0)20 7776 1200

www.nomuracode.com

Buchanan Communications

Maryί›Jane Johnson / Lisa Baderoon / Catherine Breen +44 (0) 20 7466 5000

About TyraTech

TyraTech was formed in 2004 to develop and commercialise products for the control of invertebrate pests and pathogens using the Company’s proprietary technology. TyraTech, which already has a product on the market, is positioned for human health, animal health and pesticide market opportunities which total over $23 billion globally.Β TyraTech’s technology provides the Company with a wide variety of product and business opportunities in many markets and geographic regions. The differentiating feature of these products is the potential to have a combined level of potency and safety that other invertebrate control products are unable to offer. TyraTech’s platform brings many of the principles of drug discovery and development to the fields of insecticides and parasiticides. By targeting specific chemoreceptors that are found in invertebrates but not in humans and animals, TyraTech can produce products that use natural plant derived compounds targeting these receptors.

TyraTech's plan for the use of its technology is to develop selected proprietary active ingredients which can then be used across a wide variety of market segments, either by development partners or by TyraTech itself. TyraTech already has products or partnerships in the areas of professional and horticultural insect control, and for an insect/mosquito repellent. TyraTech also has an innovative partnership with Kraft to use its natural oils to develop functional foods for improving the health of the more than 2 billion people worldwide subject to intestinal parasitic infections.

TyraTech also has a separate technology with associated intellectual property that is the basis for the Sustainable Solutions business. This technology has been incorporated into specialised dairy farm equipment for processing cattle manure waste to a usable material for TyraTech to sell as a commercial plant growing medium. For more information please visit www.tyratech.com.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTPUUAPBUPRGRG
Date   Source Headline
27th Apr 20129:59 amRNSAward of Share Options
20th Apr 20122:46 pmRNSHolding(s) in Company
18th Apr 20121:03 pmRNSHolding(s) in Company
10th Apr 20123:00 pmRNSDirector Dealing, Issue of Shares and AR Amendment
30th Mar 20122:36 pmRNSDirectorate Change
15th Mar 20125:00 pmRNSHolding(s) in Company
7th Mar 20122:04 pmRNSHolding(s) in Company
6th Mar 20127:00 amRNSIssue of Equity
5th Mar 20125:26 pmRNSHolding(s) in Company
2nd Mar 201211:42 amRNSHolding(s) in Company
27th Feb 20125:15 pmRNSResult of Special Meeting
17th Feb 201212:43 pmRNSAppointment of Joint Broker
14th Feb 20121:00 pmRNSProposed Placing and Subscription
2nd Feb 20129:00 amRNSTrading Update
1st Feb 20127:00 amRNSChange of Adviser
11th Jan 20127:00 amRNSTrading Update
7th Dec 201110:44 amRNSReplacement: Migration of Shares
7th Dec 20117:00 amRNSMigration of Shares and Block Listing Review
26th Oct 20117:00 amRNSCourt ruling in favour of TyraTech
25th Oct 20117:00 amRNSAdvisor appointed to seek Product Sale Partners
19th Oct 20117:00 amRNSTyraTech appoints a Head of European Operations
7th Oct 20117:00 amRNSMigration of shares
23rd Aug 20117:00 amRNSGerman Registrations for Three Aerosol Products
17th Aug 20117:00 amRNSDirector/PDMR Shareholding
11th Aug 20113:07 pmRNSDirector/PDMR Shareholding
11th Aug 20117:08 amRNSInterim Results
27th Jul 20115:38 pmRNSResult of AGM
30th Jun 20117:00 amRNSPosting of Annual Report and Accounts 2010
24th Jun 201112:01 pmRNSDirector/PDMR Shareholding
10th Jun 20115:55 pmRNSDirector/PDMR Shareholding
10th Jun 20115:46 pmRNSDirector/PDMR Shareholding
10th Jun 20117:00 amRNSPreliminary Results
7th Jun 20116:08 pmRNSDirector/PDMR Shareholding
1st Jun 20118:00 amRNSCourt ruling in favour of TyraTech
27th May 20114:56 pmRNSDirectorate Change
1st Mar 20118:00 amRNSShare migration to unrestricted trading line
25th Feb 20118:00 amRNSBlock listing application
4th Jan 20119:01 amRNSHolding(s) in Company
29th Dec 20102:23 pmRNSHolding(s) in Company
21st Dec 20102:26 pmRNSMajor Shareholdings
21st Dec 20109:00 amRNSIssue of Equity
30th Nov 20108:16 amRNSHolding(s) in Company
12th Nov 20103:31 pmRNSDirector Remuneration & Treasury Share Readmission
26th Oct 20102:59 pmRNSShare Migration to Unrestricted Trading Line
26th Oct 20102:59 pmRNSShare Migration to Unrestricted Trading Line
21st Oct 20103:22 pmRNSAward of Share Options
21st Oct 20103:22 pmRNSAward of Share Options
20th Oct 20107:00 amRNSSupply Agreement Signed With Terminix
6th Oct 20107:00 amRNSSignificant reorder from Terminix
4th Oct 20107:00 amRNSCorporate Broker Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.